Haleon PLC Sponsored ADR $HLN Shares Sold by Stephens Inc. AR

Stephens Inc. AR lowered its holdings in Haleon PLC Sponsored ADR (NYSE:HLN) by 3.8% in the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 91,190 shares of the company’s stock after selling 3,587 shares during the period. Stephens Inc. AR’s holdings in Haleon were worth $946,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Allspring Global Investments Holdings LLC grew its holdings in shares of Haleon by 6.1% in the first quarter. Allspring Global Investments Holdings LLC now owns 30,223 shares of the company’s stock valued at $306,000 after purchasing an additional 1,749 shares in the last quarter. Acadian Asset Management LLC acquired a new position in Haleon during the 1st quarter worth approximately $1,767,000. Arlington Partners LLC acquired a new position in Haleon during the 2nd quarter worth approximately $2,315,000. Oppenheimer & Co. Inc. grew its holdings in Haleon by 11.2% during the 1st quarter. Oppenheimer & Co. Inc. now owns 25,362 shares of the company’s stock worth $261,000 after acquiring an additional 2,564 shares in the last quarter. Finally, Concurrent Investment Advisors LLC grew its holdings in Haleon by 32.9% during the 1st quarter. Concurrent Investment Advisors LLC now owns 16,363 shares of the company’s stock worth $168,000 after acquiring an additional 4,055 shares in the last quarter. Institutional investors and hedge funds own 6.67% of the company’s stock.

Haleon Trading Down 1.3%

Shares of Haleon stock opened at $9.25 on Friday. The company has a fifty day simple moving average of $9.38 and a 200-day simple moving average of $9.98. Haleon PLC Sponsored ADR has a 12-month low of $8.71 and a 12-month high of $11.42. The company has a current ratio of 0.87, a quick ratio of 0.63 and a debt-to-equity ratio of 0.48. The stock has a market cap of $41.17 billion, a price-to-earnings ratio of 23.71, a PEG ratio of 2.74 and a beta of 0.20.

Haleon Increases Dividend

The firm also recently declared a semi-annual dividend, which was paid on Thursday, September 18th. Investors of record on Friday, August 15th were given a $0.0555 dividend. This is a positive change from Haleon’s previous semi-annual dividend of $0.05. The ex-dividend date was Friday, August 15th. This represents a yield of 190.0%. Haleon’s payout ratio is currently 28.21%.

Analysts Set New Price Targets

Several research analysts have commented on HLN shares. Wall Street Zen cut shares of Haleon from a “buy” rating to a “hold” rating in a report on Saturday, July 12th. Barclays cut shares of Haleon from an “overweight” rating to an “equal weight” rating in a report on Tuesday, September 16th. The Goldman Sachs Group upgraded shares of Haleon from a “neutral” rating to a “buy” rating in a report on Wednesday, September 10th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Haleon in a report on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $12.33.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.